Download Free Sample Report

Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but dont surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animals body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohns disease, etc.
This report contains market size and forecasts of Sulfonamides in Global, including the following market information:

• Global Sulfonamides Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global Sulfonamides market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intestinal Absorption Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sulfonamides include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sulfonamides companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sulfonamides Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Sulfonamides Market Segment Percentages, by Type, 2021 (%)

• Intestinal Absorption
• Intestinal Tract Difficult to Absorb
• External Use

Global Sulfonamides Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Sulfonamides Market Segment Percentages, by Application, 2021 (%)

• Systemic Infection
• Intestinal Infection
• Burn Infection
• Other Infections

Global Sulfonamides Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Sulfonamides Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Sulfonamides revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Sulfonamides revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Sanofi
• Roche
• Mylan
• Teva
• Bayer
• Abbott
• GlaxoSmithKline
• Boehringer Ingelheim